The store will not work correctly when cookies are disabled.
1-(2-(4'-nitrobiphenyl-4-yl)-1H-benzo[d]imidazol-5-yl)ethanone
ID: ALA2037268
PubChem CID: 70696498
Max Phase: Preclinical
Molecular Formula: C21H15N3O3
Molecular Weight: 357.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1ccc2[nH]c(-c3ccc(-c4ccc([N+](=O)[O-])cc4)cc3)nc2c1
Standard InChI: InChI=1S/C21H15N3O3/c1-13(25)17-8-11-19-20(12-17)23-21(22-19)16-4-2-14(3-5-16)15-6-9-18(10-7-15)24(26)27/h2-12H,1H3,(H,22,23)
Standard InChI Key: ZTBHGCYEVHKCHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
0.6634 -6.2773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1749 -5.6122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6094 -5.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6037 -6.7005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1848 -6.9493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3271 -5.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0383 -5.8850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0317 -6.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3148 -7.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4844 -6.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1340 -6.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7119 -5.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8890 -5.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7259 -6.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9056 -6.9782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9572 -6.2516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3752 -6.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1995 -6.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6067 -6.2388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1836 -5.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3607 -5.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4336 -6.2292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8390 -5.5105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8533 -6.9396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7562 -5.4782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7629 -4.6531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4672 -5.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
13 10 1 0
1 10 1 0
4 5 1 0
1 5 1 0
14 15 1 0
6 7 1 0
7 8 2 0
16 17 2 0
8 9 1 0
17 18 1 0
4 9 2 0
18 19 2 0
3 6 2 0
19 20 1 0
20 21 2 0
21 16 1 0
11 16 1 0
10 15 2 0
1 2 2 0
14 11 2 0
22 23 2 0
22 24 1 0
19 22 1 0
2 3 1 0
7 25 1 0
11 12 1 0
25 26 2 0
3 4 1 0
25 27 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.37 | Molecular Weight (Monoisotopic): 357.1113 | AlogP: 5.01 | #Rotatable Bonds: 4 |
Polar Surface Area: 88.89 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.94 | CX Basic pKa: 4.27 | CX LogP: 4.43 | CX LogD: 4.43 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.32 | Np Likeness Score: -1.14 |
References
1. Vitale G, Corona P, Loriga M, Carta A, Paglietti G, Giliberti G, Sanna G, Farci P, Marongiu ME, La Colla P.. (2012) 5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4., 53 [PMID:22513121] [10.1016/j.ejmech.2012.03.038] |